BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9421090)

  • 1. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen.
    DeCostanzo DC; Elias JM; Chumas JC
    Int J Gynecol Pathol; 1997 Jul; 16(3):245-9. PubMed ID: 9421090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
    Berezowski K; Stastny JF; Kornstein MJ
    Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma.
    Loy TS; Calaluce RD; Keeney GL
    Mod Pathol; 1996 Nov; 9(11):1040-4. PubMed ID: 8933513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
    Prat J
    Mod Pathol; 2005 Feb; 18 Suppl 2():S99-111. PubMed ID: 15492758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas].
    Dai L; Song Q; Li L; Zhong D; Hui Y
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):114-7. PubMed ID: 11866966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM; Meir A; Sabo E
    Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms.
    Goldstein NS; Bassi D; Uzieblo A
    Am J Clin Pathol; 2001 Aug; 116(2):246-52. PubMed ID: 11488072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas.
    Miettinen M
    Mod Pathol; 1995 May; 8(4):384-8. PubMed ID: 7567935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
    Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
    Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix.
    Guerrieri C; FrÄnlund B; Boeryd B
    Mod Pathol; 1995 Jun; 8(5):573-6. PubMed ID: 7545815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Female genital tract polyneoplasia: primary multiple neoplasms or metastases?].
    Paianidi IuG; Sel'chuk VIu; Zhordania KI; Anurova OA; Chemeris GIu; Zakharova TI; Savelov NA; Moroz EA
    Arkh Patol; 2006; 68(4):16-20. PubMed ID: 16986489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma.
    Flint A; Lloyd RV
    Arch Pathol Lab Med; 1992 Jan; 116(1):39-42. PubMed ID: 1734831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
    Pires Y; Andrade L; Cuello M; Chuaqui R
    Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
    Cao D; Ji H; Ronnett BM
    Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.